Stay updated on Open-Label Safety Study of AXS-05 in Depression Clinical Trial
Sign up to get notified when there's something new on the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page.

Latest updates to the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No changes to study content or location listings.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedMinor housekeeping updates: a new Revision: v3.4.2 tag was added and an older v3.4.1 tag was removed; there is no impact on study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedSite-wide updates: a funding-status notice has been added and the software version now shows Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check48 days agoChange DetectedThe additions and deletions are minor textual and UI metadata changes (glossary visibility toggle, QC criteria labeling, and version numbers) that do not alter core study data, eligibility criteria, results, or the study's overall purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3. No study data or public page content appears to be altered.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page adds a consolidated Locations section listing state-site locations (Arizona, Arkansas, California, Connecticut, Florida, Georgia, Idaho, Illinois, Massachusetts, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Washington) and shows Revision: v3.3.3; earlier per-state location headings appear to have been removed (v3.3.2).SummaryDifference2%

Stay in the know with updates to Open-Label Safety Study of AXS-05 in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page.